The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Nuclear SMAD4 as a predictor of survival in patientes with extremity soft tissue sarcomas submitted to neoadjuvant chemotherapy.
Isabela Werneck Cunha
No relevant relationships to disclose
Ranyell Spencer Sobreira Batista
No relevant relationships to disclose
Paulo Roberto Stevanato
No relevant relationships to disclose
Samuel Aguiar
No relevant relationships to disclose
Ademar Lopes
No relevant relationships to disclose
Celso Abdon Mello
No relevant relationships to disclose
Wilson Luiz da Costa
No relevant relationships to disclose